Your browser doesn't support javascript.
loading
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.
Schad, Sara E; Chow, Andrew; Mangarin, Levi; Pan, Heng; Zhang, Jiajia; Ceglia, Nicholas; Caushi, Justina X; Malandro, Nicole; Zappasodi, Roberta; Gigoux, Mathieu; Hirschhorn, Daniel; Budhu, Sadna; Amisaki, Masataka; Arniella, Monica; Redmond, David; Chaft, Jamie; Forde, Patrick M; Gainor, Justin F; Hellmann, Matthew D; Balachandran, Vinod; Shah, Sohrab; Smith, Kellie N; Pardoll, Drew; Elemento, Olivier; Wolchok, Jedd D; Merghoub, Taha.
Afiliación
  • Schad SE; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Chow A; Weill Cornell Medical College, New York, NY.
  • Mangarin L; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Pan H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Zhang J; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ceglia N; Weill Cornell Medical College, New York, NY.
  • Caushi JX; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY.
  • Malandro N; John Hopkins University School of Medicine, Baltimore, MD.
  • Zappasodi R; Bloomberg-Kimmel Institute for Cancer Immunotherapy at John Hopkins, Baltimore, MD.
  • Gigoux M; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hirschhorn D; John Hopkins University School of Medicine, Baltimore, MD.
  • Budhu S; Bloomberg-Kimmel Institute for Cancer Immunotherapy at John Hopkins, Baltimore, MD.
  • Amisaki M; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Arniella M; Weill Cornell Medical College, New York, NY.
  • Redmond D; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Chaft J; Weill Cornell Medical College, New York, NY.
  • Forde PM; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Gainor JF; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hellmann MD; Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY.
  • Balachandran V; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shah S; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Smith KN; Weill Cornell Medical College, New York, NY.
  • Pardoll D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Elemento O; John Hopkins University School of Medicine, Baltimore, MD.
  • Wolchok JD; Bloomberg-Kimmel Institute for Cancer Immunotherapy at John Hopkins, Baltimore, MD.
  • Merghoub T; Department of Medicine, Massachusetts General Hospital, Boston, MA.
J Exp Med ; 219(6)2022 06 06.
Article en En | MEDLINE | ID: mdl-35604411
ABSTRACT
Transcription factors ThPOK and Runx3 regulate the differentiation of "helper" CD4+ and "cytotoxic" CD8+ T cell lineages respectively, inducing single positive (SP) T cells that enter the periphery with the expression of either the CD4 or CD8 co-receptor. Despite the expectation that these cell fates are mutually exclusive and that mature CD4+CD8+ double positive (DP) T cells are present in healthy individuals and augmented in the context of disease, yet their molecular features and pathophysiologic role are disputed. Here, we show DP T cells in murine and human tumors as a heterogenous population originating from SP T cells which re-express the opposite co-receptor and acquire features of the opposite cell type's phenotype and function following TCR stimulation. We identified distinct clonally expanded DP T cells in human melanoma and lung cancer by scRNA sequencing and demonstrated their tumor reactivity in cytotoxicity assays. Our findings indicate that antigen stimulation induces SP T cells to differentiate into DP T cell subsets gaining in polyfunctional characteristics.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2022 Tipo del documento: Article
...